logo

Immunomedics Inc. (IMMU)



Trade IMMU now with
  Date
  Headline
9/19/2020 10:34:38 AM Immunomedics Says Trodelvy Extends Survival In Phase 3 ASCENT Study Of Metastatic Triple-Negative Breast Cancer
9/18/2020 8:06:00 AM Immunomedics: Early Intracranial Responses Are Encouraging In Sacituzumab Govitecan In CNS Tumors
8/17/2020 8:14:20 AM Immunomedics Reports FDA Approval Of Samsung Biologics As Antibody Manufacturer For Trodelvy
7/6/2020 7:58:03 AM Immunomedics Says Confirmatory Phase 3 ASCENT Study Of Trodelvy Met Primary Endpoint
4/29/2020 12:03:54 AM Immunomedics Prices Public Offering Of 14.74 Mln Shares At $28.50/Shr
12/26/2019 8:06:10 AM Immunomedics:FDA Oks BLA Resubmission Filing For Sacituzumab Govitecan To Treat Metastatic Triple-Negative Breast Cancer
3/7/2019 4:13:42 PM Immunomedics Appoints Barbara Duncan To Board Of Directors